54
Participants
Start Date
February 1, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Extracorporeal Shockwave Therapy (Group A)
Each patient was evaluated before treatment for trigger points; patients underwent focal ESWT (PulseWave 2 - Mectronic Medicale s.r.l.) with a specific program for muscle contractures and myofascial pain (80-100 mJ with 2250 pulses of 5-10 Hz).
Mesotherapy (Group B)
Each patient was evaluated before treatment for trigger points; after disinfection with Chlorhexidine 2% and sterile gauze, Thiocolchicoside fl 4mg/2ml, and a local anesthetic, Mepivacaine fl 10mg/1ml, diluted in 0.9% NaCl saline, for a final volume of 10 ml, were inoculated mesodermally; 6 to 12 microinjections with needle 26G 0.40x4mm, were performed.
Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone, Palermo
University of Palermo
OTHER